Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants.

CASQ2 mutations Cathecolaminergic polymorphic ventricular tachycardia Degradative pathways Small heat shock proteins

Journal

Journal of muscle research and cell motility
ISSN: 1573-2657
Titre abrégé: J Muscle Res Cell Motil
Pays: Netherlands
ID NLM: 8006298

Informations de publication

Date de publication:
09 2020
Historique:
received: 22 04 2020
accepted: 29 08 2020
pubmed: 10 9 2020
medline: 11 8 2021
entrez: 9 9 2020
Statut: ppublish

Résumé

Homozygous calsequestrin 2 (CASQ2) point mutations leads to catecholaminergic polymorphic ventricular tachycardia: a common pathogenetic feature appears to be the drastic reduction of mutant CASQ2 in spite of normal transcription. Comparative biochemical analysis of R33Q and D307H knock in mutant mice identifies different pathogenetic mechanisms for CASQ2 degradation and different molecular adaptive mechanisms. In particular, each CASQ2 point mutation evokes specific adaptive cellular and molecular processes in each of the four adaptive pathways investigated. Thus, similar clinical phenotypes and identical cellular mechanism for cardiac arrhythmia might imply different molecular adaptive mechanisms.

Identifiants

pubmed: 32902830
doi: 10.1007/s10974-020-09587-2
pii: 10.1007/s10974-020-09587-2
pmc: PMC7666291
doi:

Substances chimiques

CASQ2 protein, human 0
Calsequestrin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-258

Références

Trends Cell Biol. 2012 Aug;22(8):407-17
pubmed: 22748206
Circ Res. 2013 Mar 29;112(7):1046-58
pubmed: 23538275
J Clin Invest. 2006 Sep;116(9):2510-20
pubmed: 16932808
Biochem J. 2008 Jul 15;413(2):291-303
pubmed: 18399795
Cell Rep. 2015 Nov 3;13(5):944-56
pubmed: 26565908
Exp Cell Res. 2014 Feb 15;321(2):178-89
pubmed: 24370574
Pediatr Cardiol. 2012 Aug;33(6):959-67
pubmed: 22421959
PLoS One. 2007 Jun 06;2(6):e498
pubmed: 17551579
Cell Stress Chaperones. 2018 Jul;23(4):491-505
pubmed: 29190034
Circ Res. 2012 Mar 2;110(5):663-8
pubmed: 22298808
Oxid Med Cell Longev. 2018 Jan 18;2018:8602041
pubmed: 29576856
J Cell Biol. 2006 Jan 30;172(3):383-93
pubmed: 16449189
Antioxid Redox Signal. 2011 Jun;14(11):2179-90
pubmed: 20812860
Sci Rep. 2019 Jul 15;9(1):10179
pubmed: 31308393
Circ Res. 2009 Dec 4;105(12):1223-31
pubmed: 19850943
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12325-30
pubmed: 18711132
J Clin Invest. 2007 Jul;117(7):1814-23
pubmed: 17607358
Cell. 2006 Dec 1;127(5):999-1013
pubmed: 17129784
J Mol Cell Cardiol. 2006 Jun;40(6):846-52
pubmed: 16697404
Eur Heart J. 2015 Mar 14;36(11):686-97
pubmed: 24216388
J Biol Chem. 2007 Sep 21;282(38):28149-56
pubmed: 17664274
Science. 2003 Feb 28;299(5611):1397-400
pubmed: 12610306
J Biol Chem. 2010 Jan 29;285(5):3076-83
pubmed: 19920148
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13807-12
pubmed: 16174725
Biochem Pharmacol. 2013 Dec 1;86(11):1576-83
pubmed: 24070655
Circ Res. 2011 Jun 10;108(12):1429-38
pubmed: 21493896
Cardiovasc Res. 2008 Aug 1;79(3):500-8
pubmed: 18397962
J Biol Chem. 2004 Feb 27;279(9):7917-24
pubmed: 14676215
Pacing Clin Electrophysiol. 2013 May;36(5):e140-2
pubmed: 22650415
Trends Cell Biol. 2010 Jun;20(6):355-62
pubmed: 20356743
J Mol Cell Cardiol. 2014 Dec;77:160-7
pubmed: 25451386
J Biol Chem. 2019 Jan 18;294(3):772-782
pubmed: 30429217
J Mol Biol. 2007 Nov 2;373(4):1047-57
pubmed: 17881003
J Mol Cell Cardiol. 2011 May;50(5):872-83
pubmed: 21334344
Life Sci. 2019 Nov 15;237:116944
pubmed: 31604108
Science. 2003 Feb 28;299(5611):1394-7
pubmed: 12610305
J Mol Cell Cardiol. 2015 Jul;84:212-22
pubmed: 25981331
Mol Cell. 2014 Apr 10;54(1):166-179
pubmed: 24685158
Circulation. 2004 Oct 26;110(17):2651-7
pubmed: 15492323
Circ Res. 2008 Aug 1;103(3):298-306
pubmed: 18583715
Biochim Biophys Acta. 2015 Apr;1854(4):291-319
pubmed: 25556000
J Biol Chem. 2006 Apr 7;281(14):9650-8
pubmed: 16431915
J Mol Cell Cardiol. 2006 Sep;41(3):555-62
pubmed: 16876820
Biochim Biophys Acta. 2016 Aug;1863(8):2037-43
pubmed: 27130253
Mol Cell. 2010 Oct 22;40(2):253-66
pubmed: 20965420
J Biol Chem. 2005 Sep 30;280(39):33097-100
pubmed: 16076838

Auteurs

Giorgia Valle (G)

Department of Biomedical Sciences, University of Padova, Viale G. Colombo 3, 35121, Padova, Italy.

Michael Arad (M)

Leviev Heart Center, Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Pompeo Volpe (P)

Department of Biomedical Sciences, University of Padova, Viale G. Colombo 3, 35121, Padova, Italy. pompeo.volpe@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH